Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 8, 2019
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
Wed, August 7, 2019
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
David Lebovitz Maintained (ALNY) at Buy with Decreased Target to $124 on, Aug 7th, 2019
David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $126 to $124 on, Aug 7th, 2019.
David has made no other calls on ALNY in the last 4 months.
There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $70 on, Tuesday, April 9th, 2019
These are the ratings of the 3 analyists that currently disagree with David
- Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $128 on, Thursday, May 2nd, 2019
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $138 on, Monday, April 15th, 2019
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $116 on, Monday, April 15th, 2019
